Inactive Instrument

Other languages APTINYX

Equities

APTX

US03836N1037

Other languages

Unlock all the news: Be the first to know and act before the market!

Aptinyx Inc. Approves Liquidating Cash Distribution, Payable on or About December 29, 2023	19/12
Aptinyx Inc. Announces Chief Executive Officer Changes	03/23/03
Aptinyx Inc. Announces Management Changes	03/23/03
Aptinyx Inc. is Heading Towards Bankruptcy	23/23/23
Aptinyx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	19/23/19
Aptinyx Inc. Announces Executive Changes	05/23/05
Aptinyx Inc. Announces Departure of Andy Kidd, Chief Executive Officer	05/23/05
Aptinyx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31
Aptinyx Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	31/23/31
Aptinyx Inc. Auditor Raises 'Going Concern' Doubt	30/23/30
Aptinyx Inc. to Reduce its Workforce by Approximately 60%	01/23/01
Top Premarket Decliners	28/23/28
Aptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies	28/23/28
Aptinyx Inc. Announces Resignation of Patrick Enright from Board of Directors	02/22/02
Investors Wait on Sidelines in Premarket Ahead of Economic Reports	16/22/16
Aptinyx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/22/09
Aptinyx Completes Enrollment in Phase 2 Trial of Treatment for Cognitive Impairment Linked to Parkinson's Disease, Dementia	25/22/25
Aptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy Bodies	25/22/25
Aptinyx Says Fibromyalgia Treatment Did Not Meet Primary Endpoint in Study; Shares Plunge	12/22/12
Aptinyx Inc. Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgia	12/22/12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages APTINYX

Equities

APTX

US03836N1037

Other languages

Filters